Only half of breast cancer survivors get annual mammograms post-surgery

Contrary to breast screening recommendations, new research suggests that breast cancer survivors are not getting the recommended number of mammograms post-surgery, according to a new study published in the Journal of the National Comprehensive Cancer Network (JNCCN).  

Led by Kathryn Ruddy, MD, MPH, director of cancer survivorship for the department of oncology at the Mayo Clinic Cancer Center, researchers found that only half of insured breast cancer survivors get consistent annual mammograms for early-detection of breast cancer recurrence.  

They also found that African-American breast cancer survivors were less likely than white breast cancer survivors to receive mammograms annually, potentially contributing to higher mortality rates for African-American women.  

"The use of regular mammograms to detect a return of breast cancer before any symptoms appear is associated with better overall survival," Ruddy said in a prepared statement.  "Therefore, clinicians need to make sure that their patients are fully aware of the role these annual mammograms play in screening for new breast cancers as well as for local recurrences. Creating and implementing survivorship care plans with clear follow-up instructions may help ensure that more survivors adhere to recommended screening schedules." 

Ruddy and her colleagues followed over 27,000 patients for an average of almost three years after breast cancer surgery, with 4,790 patients being followed for at least five years.   

Only 50 percent of the patients who were followed for at least five years had at least one mammogram each of those five years, according to the researchers.  

"This lack of imaging follow-up represents a missed opportunity for identifying recurrent or new breast cancers among a high-risk patient subgroup," said Benjamin Anderson, MD, FACS, vice-chair for the NCCN Guidelines Panel for Breast Cancer. "Of equal importance, this finding illustrates that our healthcare system can fail to track sizable groups of cancer patients after completion of treatment."  

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

These risks appear to be present regardless of a person's age or health at the time of infection.

Agfa and Sectra both performed well with end-user satisfaction scores in the 2025 Best in KLAS list of radiology IT systems.